In the first two months of Q4 of 2017, the sales revenue of China’s pha𒁏rmaceutical manufacturing sector went down by 17.8% y/y to RMB 445bn, as a result of the government’s tightening control over drug prices and distribution costs. ...

In 🍸Q3 2017 China continued to implement healthcare reforms which resulted in further development and growth of the sector. According to a health management summit held in Beijing in late 2017, the country’s healthcare market will reach RMB 4 ...

China's healthcare system is hospital-centric, with public hospitals delivering app♌roximately 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...

China's healthcare system is hospital-centric, with public hospitals delivering approximate🦄ly 90% of the inpatient and outpatient care consumed in the country in both hospitals and basic medical institutions. Neꦚarly 40% of hospitals’ revenue is ...

India’s 1.3-bn population has given rise to a sizeable healthcare sector and one of the largest pharmaceutical markets in Asia. Both the healthcare and drug markets are plagued by uneven geographical spread, low levels of public🗹 expenditure🤪 and ...

China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed𝓡 in the country in both hospitals and basic medical institutions. Nearly 40% of hospitals’ revenue is ...

The Philippines healthcare and pharmaceuticals sector has grown gradually in past years due to the country’s population and economic gr🌼owth. Recently, sector growth has accelerated due to policy measures to increase the healthcare budget which ...

Indonesia's healthcare and pharmaceuticals industry is one of the least developed in ASEAN and Indonesia has low scores on most metrics – including number of hospitals and beds per 10,000 population and healthcare expendit💜ure per capita. These ...

The Malaysian healthcare and pharmaceuticals sector has been growing strongly as a result of factors 🥂including one of the highest population growth rates in the ASEAN region, increasing affluence, and growing access to healthcare funding. In ...

Thailand is the second-largest ph♏armaceutical market in S🔯outh East Asia, with sales of THB 152.9bn in 2015. The pharmaceutical industry specialises in generic drug production and this is the largest segment on the market. Spending on health is ...